No more than 300 yuan per bottle, the first domestic anti -new crown oral medicine Azf's final price is significantly lower than foreign competition

According to the Henan Daily, on August 7, the reporter learned from Henan Real Biotechnology Co., Ltd. that at present, the price of Azf, which treats the new crown pneumonia, is initially set. , Equivalent to less than 8.57 yuan per piece.

Picture source: Weibo screenshot

Azf is determined to be the first self -developed oral small crown therapy drug in China. On July 25, 2022, the State Drug Administration conducted emergency review and approval in accordance with the relevant provisions of the Drug Management Law in accordance with the relevant provisions of the Drug Management Law, and approved the conditions of Henan Real Biotechnology Co., Ltd. Azf's fixed film to increase the treatment of new crown virus treatment Application for pneumonia adaptation.

It is understood that Azf was originally used for the treatment of AIDS. The indication was approved as early as last July last year. Public information shows that the price of Azfding as AIDS drugs is 25.86 yuan/mg (piece). Based on this calculation, Azf is set to a significant decrease in the price after being treated as a new crown pneumonia. Earlier, real biological experts revealed at the telephone meeting that the amount of Azfding's new crown was 5 mg per day and a course of treatment in 7 days. Based on the price of this disclosed price, the corresponding price of the new crown single course was about 300 yuan.

Take Molnupiravir and Paxlovid of Paxlovid, Molshadon, the mainstream new crown oral medicine in the European and American markets, as an example. The price of the two drugs is relatively expensive. $ 500 a course (about 3350 yuan). In addition, PaxLovid also received conditions for approval and was included in medical insurance in China in February this year, but the price was 2300 yuan/box. Another domestic new crown oral medication, which was approved, -the VV116 of Junshi Bio was previously approved in Uzbekistan, and disclosed its price of 185 US dollars, which is about 1243 yuan.

In terms of horizontal comparison, the price advantage of Azf's fixed tablet is obvious. If it is included in medical insurance in the later period and obtained large -scale production, the price may be further reduced.

Daily Economic News

- END -